Collectively, these findings elucidate the molecular mechanism by which the BAG2‐STUB1 complex regulates STING homeostasis, underscoring BAG2's potential as a diagnostic biomarker and therapeutic target in cervical cancer. This evidence concerns the gene BAG2 and cervical carcinoma.